Your browser doesn't support javascript.
loading
Occurrence and Severity of Oral Mucositis in Brazilian Pediatric Cancer Patients
Pires, Hévila de Figueiredo; Bezerra, Paula Maria Maracajá; Silva, Victor Borges da; Ribeiro, Isabella Lima Arrais; Serpa, Eliane Batista Medeiros; Sousa, Simone Alves de; Valença, Ana Maria Gondim.
  • Pires, Hévila de Figueiredo; Private Practice. João Pessoa. BR
  • Bezerra, Paula Maria Maracajá; Federal University of Paraíba. Postgraduate Program in Dentistry. School of Dentistry. João Pessoa. BR
  • Silva, Victor Borges da; Federal University of Paraíba. Department of Statistics. João Pessoa. BR
  • Ribeiro, Isabella Lima Arrais; Post-Doctoral Fellow, São Paulo University. Ribeirão Preto. BR
  • Serpa, Eliane Batista Medeiros; Federal University of Paraíba. Department of Clinical and Social Dentistry. João Pessoa. BR
  • Sousa, Simone Alves de; Federal University of Paraíba. Department of Clinical and Social Dentistry. João Pessoa. BR
  • Valença, Ana Maria Gondim; Federal University of Paraíba. Department of Statistics. João Pessoa. BR
Article in English | LILACS, BBO | ID: biblio-1135561
ABSTRACT
Abstract

Objective:

To determine the occurrence and severity of oral mucositis (OM) and the factors associated with the onset of severe oral mucositis (SOM) in pediatric cancer patients. Material and

Methods:

This was a longitudinal and prospective study with 85 children and adolescents (aged 0 to 19 years) admitted to the Pediatric Oncology Sector of Napoleão Laureano Hospital between November 2016 and July 2019. The patients' sociodemographic and epidemiological information, as well as hematological and biochemical parameters, were obtained from their medical charts. The oral mucosa of study participants was assessed through the modified Oral Assessment Guide (OAG) at baseline and after the 2nd, 5th and 10th week of antineoplastic treatment. Data were analyzed by Chi-square test to determine the factors associated with the occurrence of SOM (p<0.05).

Results:

The occurrence of OM was more frequent in the 2nd (60%), 5th (40.9%) and 10th week (43.2%) of antineoplastic treatment. During the follow-up period, SOM was more frequent in the 5th week (34.7%), followed by the 2nd (32.3%) and 10th weeks (29.7%). There was no association between the occurrence of SOM and the patient's age, type of tumor, chemotherapy regimen, and hematological and biochemical parameters.

Conclusion:

The occurrence of oral mucositis in pediatric cancer patients was significant, especially in the 2nd week of antineoplastic treatment. Severe oral mucositis was more prevalent in the 5th week of treatment and was not associated with any of the study variables.
Subject(s)


Full text: Available Index: LILACS (Americas) Main subject: Stomatitis / Brazil / Oncology Service, Hospital / Mouth Mucosa / Antineoplastic Agents Type of study: Observational study / Risk factors Limits: Adolescent / Adult / Child / Female / Humans / Male / Infant, Newborn Country/Region as subject: South America / Brazil Language: English Journal: Pesqui. bras. odontopediatria clín. integr Journal subject: Dentistry Year: 2020 Type: Article Affiliation country: Brazil Institution/Affiliation country: Federal University of Paraíba/BR / Post-Doctoral Fellow, São Paulo University/BR / Private Practice/BR

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Index: LILACS (Americas) Main subject: Stomatitis / Brazil / Oncology Service, Hospital / Mouth Mucosa / Antineoplastic Agents Type of study: Observational study / Risk factors Limits: Adolescent / Adult / Child / Female / Humans / Male / Infant, Newborn Country/Region as subject: South America / Brazil Language: English Journal: Pesqui. bras. odontopediatria clín. integr Journal subject: Dentistry Year: 2020 Type: Article Affiliation country: Brazil Institution/Affiliation country: Federal University of Paraíba/BR / Post-Doctoral Fellow, São Paulo University/BR / Private Practice/BR